HIGHLIGHTS
- who: Dorota Whitmer and colleagues from the Uniformed Services University of Health Sciences, United States have published the research work: Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations, in the Journal: (JOURNAL)
- what: As described in the Afirma XA analytical and clinical validation study, for research purposes only, molecular variants can be detected in the GSC-B category though these are not reported clinically . The authors have investigated the epidemiology of TSHR variants in ITN submitted for molecular analysis by the frontiersin.org 10.3389/fendo.2022.1073592 the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.